| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 93.315 | 110.181 | 117.433 | 65.299 | 121.271 | 52.387 | 161.917 | 177.536 | 138.389 | 173.181 |
| Total Income - EUR | 104.004 | 119.969 | 131.988 | 67.978 | 123.032 | 53.620 | 165.217 | 186.544 | 144.045 | 189.670 |
| Total Expenses - EUR | 24.891 | 37.899 | 47.044 | 32.598 | 33.898 | 18.737 | 39.263 | 52.309 | 61.938 | 55.424 |
| Gross Profit/Loss - EUR | 79.113 | 82.070 | 84.944 | 35.379 | 89.134 | 34.883 | 125.954 | 134.235 | 82.107 | 134.246 |
| Net Profit/Loss - EUR | 66.001 | 68.850 | 82.351 | 34.709 | 87.921 | 34.386 | 124.384 | 132.454 | 80.833 | 129.424 |
| Employees | 0 | 1 | 1 | 1 | 1 | 0 | 2 | 1 | 2 | 2 |
Check the financial reports for the company - R&D Medconsult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.211 | 8.795 | 5.627 | 2.233 | 1.678 | 505 | 1.417 | 668 | 111 | 808 |
| Current Assets | 189.589 | 82.008 | 85.027 | 43.209 | 93.832 | 47.351 | 145.218 | 143.152 | 116.644 | 208.666 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 162 | 0 | 0 |
| Receivables | 0 | 34.136 | 9.537 | 24.762 | 32.514 | 9.433 | 28.367 | 127.775 | 11.602 | 101.137 |
| Cash | 27.446 | 29.104 | 22.962 | 18.447 | 61.318 | 37.918 | 116.851 | 15.215 | 28.012 | 21.890 |
| Shareholders Funds | 174.079 | 75.233 | 88.626 | 40.869 | 93.961 | 40.312 | 143.374 | 138.267 | 116.125 | 135.186 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.720 | 16.143 | 2.028 | 4.572 | 1.548 | 7.544 | 3.506 | 5.553 | 1.751 | 74.565 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - R&D Medconsult Srl